BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21562322)

  • 1. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.
    Agardh E; Tababat-Khani P
    Diabetes Care; 2011 Jun; 34(6):1318-9. PubMed ID: 21562322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    ; Nathan DM; Bebu I; Hainsworth D; Klein R; Tamborlane W; Lorenzi G; Gubitosi-Klug R; Lachin JM
    N Engl J Med; 2017 Apr; 376(16):1507-1516. PubMed ID: 28423305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography.
    Liesenfeld B; Kohner E; Piehlmeier W; Kluthe S; Aldington S; Porta M; Bek T; Obermaier M; Mayer H; Mann G; Holle R; Hepp KD
    Diabetes Care; 2000 Mar; 23(3):345-8. PubMed ID: 10868863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal examination intervals in diabetic patients on diet treatment only.
    Hansson-Lundblad C; Agardh E; Agardh CD
    Acta Ophthalmol Scand; 1997 Jun; 75(3):244-8. PubMed ID: 9253966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal microaneurysm counts and 10-year progression of diabetic retinopathy.
    Klein R; Meuer SM; Moss SE; Klein BE
    Arch Ophthalmol; 1995 Nov; 113(11):1386-91. PubMed ID: 7487599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
    Groeneveld Y; Tavenier D; Blom JW; Polak BCP
    Diabet Med; 2019 Oct; 36(10):1199-1208. PubMed ID: 30677170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
    Younis N; Broadbent DM; Vora JP; Harding SP;
    Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-field photography can identify patients with vision-threatening diabetic retinopathy: a screening approach in the primary care setting.
    Stellingwerf C; Hardus PL; Hooymans JM
    Diabetes Care; 2001 Dec; 24(12):2086-90. PubMed ID: 11723088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is one 60 degrees fundus photograph sufficient for screening of proliferative diabetic retinopathy?
    Møller F; Hansen M; Sjølie AK
    Diabetes Care; 2001 Dec; 24(12):2083-5. PubMed ID: 11723087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus.
    Lee KM; Sum WM
    Clin Exp Optom; 2011 Jul; 94(4):371-5. PubMed ID: 21323731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
    Olafsdóttir E; Stefánsson E
    Br J Ophthalmol; 2007 Dec; 91(12):1599-601. PubMed ID: 17627978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical Macular Edema as a Predictor of Progression to Central-Involved Macular Edema in Type 2 Diabetes.
    Lobo C; Pires I; Alves D; Pappuru R; Ribeiro L; Cunha-Vaz J
    Ophthalmic Res; 2018; 60(1):18-22. PubMed ID: 29510401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy.
    Bresnick GH; Mukamel DB; Dickinson JC; Cole DR
    Ophthalmology; 2000 Jan; 107(1):19-24. PubMed ID: 10647713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography.
    Regatieri CV; Branchini L; Carmody J; Fujimoto JG; Duker JS
    Retina; 2012 Mar; 32(3):563-8. PubMed ID: 22374157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
    Younis N; Broadbent DM; Harding SP; Vora JP
    Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.
    Haritoglou C; Kernt M; Neubauer A; Gerss J; Oliveira CM; Kampik A; Ulbig M
    Retina; 2014 Jan; 34(1):157-64. PubMed ID: 23792485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy in a remote Indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project.
    Brazionis L; Jenkins A; Keech A; Ryan C; Brown A; Boffa J; Bursell S;
    Diabet Med; 2018 May; 35(5):630-639. PubMed ID: 29405370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.